CN103127325A - Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof - Google Patents
Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof Download PDFInfo
- Publication number
- CN103127325A CN103127325A CN2013100969097A CN201310096909A CN103127325A CN 103127325 A CN103127325 A CN 103127325A CN 2013100969097 A CN2013100969097 A CN 2013100969097A CN 201310096909 A CN201310096909 A CN 201310096909A CN 103127325 A CN103127325 A CN 103127325A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- hepatitis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 208000006454 hepatitis Diseases 0.000 title abstract 3
- 231100000283 hepatitis Toxicity 0.000 title abstract 3
- 241000222336 Ganoderma Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 241001071795 Gentiana Species 0.000 claims abstract description 9
- 208000002672 hepatitis B Diseases 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241000545442 Radix Species 0.000 claims description 8
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 27
- 238000005516 engineering process Methods 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 14
- 238000009826 distribution Methods 0.000 description 12
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000003494 hepatocyte Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine compound for treatment of hepatitis and a preparation method thereof. The traditional Chinese medicine compound is characterized by being prepared by the following raw materials according to parts by weight: 10-20 parts of oldenlandia diffusa, 10-20 parts of dandelion, 10-20 parts of lucid ganoderma, 10-20 parts of barbary wolfberry fruit, 7-13 parts of gentian, 8-12 parts of astragalus mongholicus, 8-12 parts of oriental wormwood, 8-12 parts of radix bupleuri, 8-12 parts of schisandra chinensis, 6-10 parts of rhizoma alismatis, 6-10 parts of salvia miltiorrhiza, and 4-8 parts of golden cypress. The traditional Chinese medicine compound has the advantages of good and fast curative effect, no side effects, advanced preparation technology, good stability of the preparation, high availability of the compound, and the like; and clinical verifications show that the effect rate of the traditional Chinese medicine compound in treating hepatitis is 94%.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicine pharmacy, particularly relate to a kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof.
Background technology
Hepatitis B is a kind of by caused disease after hepatitis B virus (HBV) infection body.Hepatitis B virus is a kind of Hepadna Virus, mainly is present in hepatocyte and damages hepatocyte, causes hepatocyte inflammation, necrosis, fibrosis.
At present, although there is the medicine of multiple treatment hepatitis B, curative effect is not good enough mostly, and treatment time is long, and side effect is large, therefore studies a kind of good effect, instant effect, and the Chinese medicine composition of the treatment hepatitis B that side effect is little is very necessary.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of hepatitis B and preparation method thereof, the present invention has good effect, instant effect has no side effect, and preparation technology is advanced, better stability of preparation, drug utilization degree advantages of higher.
A kind of Chinese medicine composition for the treatment of hepatitis B is characterized in that: the crude drug by following weight portion is made: Herba Hedyotidis Diffusae 10-20 part, Herba Taraxaci 10-20 part, Ganoderma 10-20 part, Fructus Lycii 10-20 part, Radix Gentianae 7-13 part, Radix Astragali 8-12 part, Herba Artemisiae Scopariae 8-12 part, Radix Bupleuri 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Rhizoma Alismatis 6-10 part, Radix Salviae Miltiorrhizae 6-10 part, Cortex Phellodendri 4-8 part.
The Chinese medicine composition for the treatment of hepatitis B according to claim 1 is characterized in that: the crude drug by following weight portion is made: 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Herba Taraxacis, 15 parts of Ganodermas, 15 parts of Fructus Lycii, 10 parts of Radix Gentianaes, 10 parts of the Radixs Astragali, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 10 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Alismatis, 8 parts of Radix Salviae Miltiorrhizaes, 6 parts of Cortex Phellodendris.
The preparation method of the Chinese medicine composition of described treatment hepatitis B comprises the following steps:
(1) according to described parts by weight weighting raw materials: Herba Hedyotidis Diffusae, Herba Taraxaci, Ganoderma, Fructus Lycii, Radix Gentianae, the Radix Astragali, Herba Artemisiae Scopariae, Radix Bupleuri, Fructus Schisandrae Chinensis, Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Cortex Phellodendri are standby;
(2) add 8-12 times of water gaging of total raw material medicine to soak 1-1.5 hour, heating decocted 1-3 hour, filtered, and medicinal residues add 6-8 times of water gaging again, and heating decocted 1-1.5 hour, filtered, and filtrate merges, and gets supernatant;
When (3) supernatant concentration to relative density is 1.1-1.3, advance spray dryer, inlet temperature is controlled 140-180 ℃, and leaving air temp 80-110 ℃, charging rate is 1L/ minute, gets spray drying powder;
(4) with dry powder with No. 0 capsule fill, sterilization, packing gets final product.
Instructions of taking: one day three times, one time 10,30 days is a course for the treatment of.
The pharmaceutical characteristic of each crude drug of the present invention is as follows:
Herba Hedyotidis Diffusae: meridian distribution of property and flavor: sweet, light, cool, return stomach, large intestine, small intestine meridian; Effect: heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain.
Herba Taraxaci: meridian distribution of property and flavor: bitter, sweet, cold liver, the stomach warp of returning; Effect: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, inducing diuresis for treating stranguria syndrome.
Ganoderma: meridian distribution of property and flavor: sweet, flat, GUIXIN, lung, liver, kidney channel; Effect: invigorating QI and tranquilization, relieving cough and asthma.
Fructus Lycii: meridian distribution of property and flavor: sweet, flat, return liver, kidney channel; Effect: nourishing the liver and kidney, replenishing vital essence to improve eyesight.
Radix Gentianae: meridian distribution of property and flavor: bitter, cold, return liver, gallbladder meridian; Effect: heat clearing and damp drying, eliminating pathogen in the liver gallbladder fire.
The Radix Astragali: meridian distribution of property and flavor: sweet, tepor is returned lung, spleen, liver, kidney channel; Effect: polishing consolidating superficial resistance, holder skin ulcer granulation promoting.
Herba Artemisiae Scopariae: meridian distribution of property and flavor: bitter, hot, be slightly cold, return spleen, stomach, liver, gallbladder meridian; Effect: clearing away damp-heat, jaundice eliminating subcutaneous ulcer.
Radix Bupleuri: meridian distribution of property and flavor: bitter, be slightly cold, return liver, gallbladder meridian; Effect: reconciling superficies and interior, soothing the liver, yang invigorating.
Fructus Schisandrae Chinensis: meridian distribution of property and flavor: sour, sweet, warm, return lung, the heart, kidney channel; Effect: restrain astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.
Rhizoma Alismatis: meridian distribution of property and flavor: sweet, cold, return kidney, urinary bladder channel; Effect: diuresis, clearing away damp-heat.
Radix Salviae Miltiorrhizae: meridian distribution of property and flavor: bitter, be slightly cold, GUIXIN, Liver Channel; Effect: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Cortex Phellodendri: meridian distribution of property and flavor: bitter, cold, return kidney, urinary bladder channel; Effect: heat clearing and damp drying, pathogenic fire purging is except steaming, detoxification sore treatment.
The beneficial effect that the present invention compared with prior art has is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, chooses each crude drug and proportioning thereof, reaches benefiting QI for activating blood circulation, purging liver-fire, kidney-supplementing liver-boosting, yin nourishing easing the affected liver, promoting blood circulation and stopping pain, the effect of heat-clearing and toxic substances removing; The present invention has good effect, and instant effect has no side effect, and preparation technology is advanced, better stability of preparation, drug utilization degree advantages of higher; Through clinical verification, it is 94% that the present invention treats the hepatitis B effective percentage.
The specific embodiment
Embodiment 1:
A kind of Chinese medicine composition for the treatment of hepatitis B is made by the crude drug of following weight portion: 10 parts of Herba Hedyotidis Diffusaes, 10 parts of Herba Taraxacis, 10 parts of Ganodermas, Fructus Lycii 10,7 parts of Radix Gentianaes, 8 parts of the Radixs Astragali, 8 parts of Herba Artemisiae Scopariaes, 8 parts of Radix Bupleuri, 8 parts of Fructus Schisandrae Chinensis, 6 parts of Rhizoma Alismatis, 6 parts of Radix Salviae Miltiorrhizaes, 4 parts of Cortex Phellodendris.
The preparation method of the Chinese medicine composition of described treatment hepatitis B comprises the following steps:
(1) according to described parts by weight weighting raw materials: 10 parts of Herba Hedyotidis Diffusaes, 10 parts of Herba Taraxacis, 10 parts of Ganodermas, Fructus Lycii 10,7 parts of Radix Gentianaes, 8 parts of the Radixs Astragali, 8 parts of Herba Artemisiae Scopariaes, 8 parts of Radix Bupleuri, 8 parts of Fructus Schisandrae Chinensis, 6 parts of Rhizoma Alismatis, 6 parts of Radix Salviae Miltiorrhizaes, 4 parts of Cortex Phellodendris are standby;
(2) add 12 times of water gagings of total raw material medicine to soak 1.5 hours, heating decocted 2 hours, filtered, and medicinal residues add 8 times of water gagings again, and heating decocted 1.5 hours, filtered, and filtrate merges, and gets supernatant;
(3) supernatant concentration to relative density is 1.1 o'clock, advances spray dryer, and inlet temperature is controlled 160 ℃, 100 ℃ of leaving air temps, and charging rate is 1L/ minute, gets spray drying powder;
(4) with dry powder with No. 0 capsule fill, sterilization, packing gets final product.
Embodiment 2:
A kind of Chinese medicine composition for the treatment of hepatitis B is made by the crude drug of following weight portion: 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Herba Taraxacis, 15 parts of Ganodermas, 15 parts of Fructus Lycii, 10 parts of Radix Gentianaes, 10 parts of the Radixs Astragali, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 10 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Alismatis, 8 parts of Radix Salviae Miltiorrhizaes, 6 parts of Cortex Phellodendris.
The preparation method of the Chinese medicine composition of described treatment hepatitis B comprises the following steps:
(1) according to described parts by weight weighting raw materials: 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Herba Taraxacis, 15 parts of Ganodermas, 15 parts of Fructus Lycii, 10 parts of Radix Gentianaes, 10 parts of the Radixs Astragali, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 10 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Alismatis, 8 parts of Radix Salviae Miltiorrhizaes, 6 parts of Cortex Phellodendris are standby;
(2) add 10 times of water gagings of total raw material medicine to soak 1 hour, heating decocted 3 hours, filtered, and medicinal residues add 6 times of water gagings again, and heating decocted 1 hour, filtered, and filtrate merges, and gets supernatant;
(3) supernatant concentration to relative density is 1.2 o'clock, advances spray dryer, and inlet temperature is controlled 150 ℃, 900 ℃ of leaving air temps, and charging rate is 1L/ minute, gets spray drying powder;
(4) with dry powder with No. 0 capsule fill, sterilization, packing gets final product.
Embodiment 3:
A kind of Chinese medicine composition for the treatment of hepatitis B is made by the crude drug of following weight portion: 20 parts of Herba Hedyotidis Diffusaes, 20 parts of Herba Taraxacis, 20 parts of Ganodermas, 20 parts of Fructus Lycii, 13 parts of Radix Gentianaes, 12 parts of the Radixs Astragali, 12 parts of Herba Artemisiae Scopariaes, 12 parts of Radix Bupleuri, 12 parts of Fructus Schisandrae Chinensis, 10 parts of Rhizoma Alismatis, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Cortex Phellodendris.
The preparation method of the Chinese medicine composition of described treatment hepatitis B comprises the following steps:
(1) according to described parts by weight weighting raw materials: 20 parts of Herba Hedyotidis Diffusaes, 20 parts of Herba Taraxacis, 20 parts of Ganodermas, 20 parts of Fructus Lycii, 13 parts of Radix Gentianaes, 12 parts of the Radixs Astragali, 12 parts of Herba Artemisiae Scopariaes, 12 parts of Radix Bupleuri, 12 parts of Fructus Schisandrae Chinensis, 10 parts of Rhizoma Alismatis, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Cortex Phellodendris are standby;
(2) add 11 times of water gagings of total raw material medicine to soak 1.2 hours, heating decocted 1.5 hours, filtered, and medicinal residues add 7 times of water gagings again, and heating decocted 1 hour, filtered, and filtrate merges, and gets supernatant;
(3) supernatant concentration to relative density is 1.18 o'clock, advances spray dryer, and inlet temperature is controlled 170 ℃, 95 ℃ of leaving air temps, and charging rate is 1L/ minute, gets spray drying powder;
(4) with dry powder with No. 0 capsule fill, sterilization, packing gets final product.
Experimental example:
One, clinical data: adopt the present invention to treat altogether 108 routine hepatitis B patients, male 73 examples wherein, female's 35 examples, the oldest 60 years old, minimum 10 years old of age.
Two, clinical symptoms: low grade fever, weak, dizzy, loss of appetite, feel sick, vomit, detest oil, abdominal distention, yellowish urine, uncomfortable liver area, sleep is not good enough etc.
Three, Therapeutic Method: the patient takes night and morning every day, and 30 days is a course for the treatment of.
Four, the standard of curative effect evaluation:
Cure: transference cure, experimental check is normal;
Take a turn for the better: symptom is obviously improved, and lab testing is improved;
Do not heal: primary symptom is not improved or deterioration person.
Five, model case:
1, Wang, the man 48 years old, suffered from hepatitis B more than ten years.Outpatient service disease is seen: complexion is white, coldness of the body with chills, and the epigastrium cold type of pain is liked warm aversion to cold, limbs fatigue, the poor dreaminess of sleeping is felt sick sometimes.Laboratory report: ALT fluctuation is in the 120IU/L left and right, and the serum bilirubin fluctuation is in the 30mol/L left and right.Take Chinese medicine composition of the present invention after 2 courses for the treatment of symptom obviously improve, take 3 recoveries from illness courses for the treatment of; Followed up a case by regular visits to 1 year, not recurrence.
2, Liu, the man, 36 years old, before January, ALT 340IU/L was found in health check-up, and serum bilirubin fluctuates at 20mol/L, and hepatitis B three is that chemical examination is great three positive, and except fatiguability one disease, all the other are showed no obvious abnormalities.Outpatient service disease is seen: red tongue with thin and yellow fur is greasy and dry, and xerostomia is thirsty, constipation with dry stool, and complexion is partially red.Take Chinese medicine composition of the present invention after 1 course for the treatment of liver function test all normal, take after 2 courses for the treatment of hepatitis B three and be that chemical examination turns entirely is shady, clinical symptom disappearance and fully recovering.
3, Zhao so-and-so, the man, 24 years old, suffer from hepatitis B more than a year, feel uncomfortable liver area when dry weight is lived, the time have weak, anorexia, yellow urine is liked angryly, is afraid of to suffer from cold, take Chinese medicine composition of the present invention after 1 course for the treatment of all diseases disappear, more after without recurrence.
Six, therapeutic outcome:
Adopt the present invention to treat altogether hepatitis B patient 118 examples, through the treatment of 1-6 the course for the treatment of, wherein cure 99 examples, 12 examples that take a turn for the better, 7 examples that do not heal, effective percentage is 94%; Result shows, the present invention has good effect to the treatment hepatitis B, and instant effect has no side effect, and preparation technology is advanced, better stability of preparation, drug utilization degree advantages of higher.
Claims (3)
1. Chinese medicine composition for the treatment of hepatitis B, it is characterized in that: the crude drug by following weight portion is made: Herba Hedyotidis Diffusae 10-20 part, Herba Taraxaci 10-20 part, Ganoderma 10-20 part, Fructus Lycii 10-20 part, Radix Gentianae 7-13 part, Radix Astragali 8-12 part, Herba Artemisiae Scopariae 8-12 part, Radix Bupleuri 8-12 part, Fructus Schisandrae Chinensis 8-12 part, Rhizoma Alismatis 6-10 part, Radix Salviae Miltiorrhizae 6-10 part, Cortex Phellodendri 4-8 part.
2. the Chinese medicine composition for the treatment of hepatitis B according to claim 1, it is characterized in that: the crude drug by following weight portion is made: 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Herba Taraxacis, 15 parts of Ganodermas, 15 parts of Fructus Lycii, 10 parts of Radix Gentianaes, 10 parts of the Radixs Astragali, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Bupleuri, 10 parts of Fructus Schisandrae Chinensis, 8 parts of Rhizoma Alismatis, 8 parts of Radix Salviae Miltiorrhizaes, 6 parts of Cortex Phellodendris.
3. the preparation method of the Chinese medicine composition of described treatment hepatitis B comprises the following steps:
(1) according to described parts by weight weighting raw materials: Herba Hedyotidis Diffusae, Herba Taraxaci, Ganoderma, Fructus Lycii, Radix Gentianae, the Radix Astragali, Herba Artemisiae Scopariae, Radix Bupleuri, Fructus Schisandrae Chinensis, Rhizoma Alismatis, Radix Salviae Miltiorrhizae, Cortex Phellodendri are standby;
(2) add 8-12 times of water gaging of total raw material medicine to soak 1-1.5 hour, heating decocted 1-3 hour, filtered, and medicinal residues add 6-8 times of water gaging again, and heating decocted 1-1.5 hour, filtered, and filtrate merges, and gets supernatant;
When (3) supernatant concentration to relative density is 1.1-1.3, advance spray dryer, inlet temperature is controlled 140-180 ℃, and leaving air temp 80-110 ℃, charging rate is 1L/ minute, gets spray drying powder;
(4) with dry powder with No. 0 capsule fill, sterilization, packing gets final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100969097A CN103127325A (en) | 2013-03-25 | 2013-03-25 | Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100969097A CN103127325A (en) | 2013-03-25 | 2013-03-25 | Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103127325A true CN103127325A (en) | 2013-06-05 |
Family
ID=48488195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100969097A Pending CN103127325A (en) | 2013-03-25 | 2013-03-25 | Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103127325A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751658A (en) * | 2014-02-22 | 2014-04-30 | 储可英 | Drug for treating serum hepatitis caused by damp-heat brewing and preparation method thereof |
| CN104645082A (en) * | 2015-03-23 | 2015-05-27 | 傅宇晓 | Capsule for treating hepatitis and preparation method thereof |
| CN104758717A (en) * | 2015-03-17 | 2015-07-08 | 朱克兰 | Traditional Chinese medicine composition for treating chronic hepatitis |
| CN105999097A (en) * | 2016-07-08 | 2016-10-12 | 王恩禄 | Traditional Chinese medicine composition for treating hepatitis B |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079157A (en) * | 1993-03-20 | 1993-12-08 | 赵三立 | Medicine " Ganyanfukangling " for curing hepatitis |
| CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
| CN101040960A (en) * | 2007-04-27 | 2007-09-26 | 蒋保珍 | Medicine for treating hepatitis |
| CN102698083A (en) * | 2012-07-04 | 2012-10-03 | 贵阳中医学院 | Oldenlandia liver-tonifying and toxicity-eliminating particles and preparation method thereof, as well as detection method |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
-
2013
- 2013-03-25 CN CN2013100969097A patent/CN103127325A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079157A (en) * | 1993-03-20 | 1993-12-08 | 赵三立 | Medicine " Ganyanfukangling " for curing hepatitis |
| CN1380098A (en) * | 2002-05-20 | 2002-11-20 | 张勇飞 | Anti-infection compound preparation and its preparation method |
| CN101040960A (en) * | 2007-04-27 | 2007-09-26 | 蒋保珍 | Medicine for treating hepatitis |
| CN102698083A (en) * | 2012-07-04 | 2012-10-03 | 贵阳中医学院 | Oldenlandia liver-tonifying and toxicity-eliminating particles and preparation method thereof, as well as detection method |
| CN102755594A (en) * | 2012-07-19 | 2012-10-31 | 杨国兴 | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751658A (en) * | 2014-02-22 | 2014-04-30 | 储可英 | Drug for treating serum hepatitis caused by damp-heat brewing and preparation method thereof |
| CN103751658B (en) * | 2014-02-22 | 2015-11-11 | 储可英 | A kind ofly treat medicine of the hepatitis B that damp-heat accumulation causes and preparation method thereof |
| CN104758717A (en) * | 2015-03-17 | 2015-07-08 | 朱克兰 | Traditional Chinese medicine composition for treating chronic hepatitis |
| CN104645082A (en) * | 2015-03-23 | 2015-05-27 | 傅宇晓 | Capsule for treating hepatitis and preparation method thereof |
| CN104645082B (en) * | 2015-03-23 | 2017-12-15 | 应瑶琪 | A kind of capsule for treating hepatitis and preparation method thereof |
| CN105999097A (en) * | 2016-07-08 | 2016-10-12 | 王恩禄 | Traditional Chinese medicine composition for treating hepatitis B |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103127378B (en) | Chinese medicinal composition for treating rheumatic heart disease | |
| CN103120791B (en) | A kind of Chinese medicine composition for the treatment of viral myocarditis and preparation method thereof | |
| CN103110844B (en) | Traditional Chinese medicine for treating acute tonsillitis | |
| CN103272199B (en) | Frostbite treatment medicine | |
| CN102552697B (en) | Chinese medicinal preparation for treating hand-foot-mouth disease | |
| CN101085242A (en) | Traditional Chinese medicine composition for treating oral cavity ulcer | |
| CN102657807B (en) | Chinese medicinal composition for treating radiation proctitis | |
| CN104001008A (en) | Traditional Chinese medicine composition treating tinnitus cerebri with syndrome of marrow depletion due to kidney deficiency and preparation method thereof | |
| CN103127325A (en) | Traditional Chinese medicine compound for treatment of hepatitis and preparation method thereof | |
| CN102895561A (en) | Traditional Chinese medical composition for treatment of restless leg syndrome | |
| CN102614405B (en) | Traditional Chinese medicine decoction for curing limb pain caused by diabetic neuropathy | |
| CN101428114B (en) | Medicament for treating chronic hepatitis B, cirrhosis and liver ascites | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN103127470A (en) | Traditional Chinese medicine composition for treating coronary diseases | |
| CN101721653A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
| CN104758845A (en) | External traditional Chinese medicine ointment for treating scapulohumeral periarthritis | |
| CN103816485A (en) | Traditional Chinese medicine composition for treating scleredema neonatorum and preparation method of traditional Chinese medicine composition | |
| CN103845580A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN103110811B (en) | Traditional Chinese medicine composition for treating arrhythmia | |
| CN102370853A (en) | Traditional Chinese medicine for treating chronic pyelonephritis | |
| CN103550615A (en) | Traditional Chinese medicine for treating spleen-kidney deficiency scouring disease | |
| CN102846772B (en) | Navel-applied plaster for treating senile constipation and preparation method thereof | |
| CN102370825B (en) | Traditional Chinese medicine for treating eczema | |
| CN102614420A (en) | Chinese medicine preparation for curing atrophic glossitis | |
| CN103536853B (en) | The Chinese medicine for the treatment of deficiency of both the heart and spleen pattern of syndrome spleen fatiguing disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130605 |